))
EXTENDED: The ‘Chemical Vaccine’ for Long-Lasting Malaria Prevention (with Theresa Shapiro)
Manage episode 386207095 series 3531530
Content provided by Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
An old malaria drug gets a new formulation. But how good is it – and will it drive resistance?
In this podcast, we ask:
- What are the limitations of current malaria vaccines?
- What is the concept of long-acting injectable (LAI) drugs?
- What are the clinical and chemical properties of atovaquone that make it suitable for this purpose?
With Theresa Shapiro, Professor, Johns Hopkins School of Medicine and Division Director, Division of Clinical Pharmacology.
About The PodcastThe Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
65 episodes
Share
